Tag Archives: Gordon Broderick

Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression

Posted on May 20, 2019 by wames

Treatment avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a split-gender pharmacogenomic study of gene-expression modules, by Mary G Jeffrey, Lubov Nathanson, Kristina Aenlle, Zachary M Barnes, Mirza Baig, Gordon Broderick, Nancy G Klimas, Mary Ann Fletcher, Travis JA Craddock in Clinical … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression

Endocrine immune regulation in… women with CFS

Posted on April 24, 2019 by wames

Leveraging prior knowledge of endocrine immune regulation in the therapeutically relevant phenotyping of women with Chronic Fatigue Syndrome, by Matthew C Morris, Katherine Cooney, Hooman Sedghamiz, Maria Abreu, Fanny Collado, Elizabeth G Balbin, Travis JA Craddock, Nancy G Klimas, Gordon … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Endocrine immune regulation in… women with CFS

Pharmaceutical interventions in CFS: a literature-based commentary

Posted on March 21, 2019 by wames

Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary, by  Spencer Richman, Matthew C Morris, Gordon Broderick, Travis JA Craddock, Nancy G Klimas, Mary Ann Fletcher in Clinical Therapeutics [Available online 11 March 2019] Research abstract: Myalgic encephalomyelitis/chronic fatigue syndrome … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on Pharmaceutical interventions in CFS: a literature-based commentary